FDA Brief

Warning letters Food

FDA warning letter to

Good Stuff Cacao

LowIssued Jul 2Posted Sep 29Human Foods Program

FDA warns Good Stuff Cacao that disease claims make its cacao, tea, honey, goji unapproved new drugs.

What happened

FDA reviewed the company's website in April 2026 and found that it takes orders there for Goji Berries, Green Tea, Raw Cacao Powder, and Crystalized Raw Honey. The website's label images and claims said these products treat or prevent diseases, including cancer, diabetes, heart disease, Alzheimer's, Parkinson's, and tooth decay. FDA also found that Goji Berries, Green Tea, and Raw Cacao Powder lack adequate directions for their intended disease uses and are misbranded drugs.

What FDA found

  1. Website and label claims state that Goji Berries are intended to treat cancer, diabetes, or microbes, which makes them a drug.

    Federal Food, Drug, and Cosmetic Act section 201(g)(1)(B) [21 U.S.C. 321(g)(1)(B)]
  2. Website and label claims state that Green Tea is intended to lower heart disease risk, fight Alzheimer's and Parkinson's, or reduce anxiety, which makes it a drug.

    Federal Food, Drug, and Cosmetic Act section 201(g)(1)(B) [21 U.S.C. 321(g)(1)(B)]
  3. Website and label claims state that Raw Cacao Powder is intended to fight tooth decay, regulate blood sugar, or lower blood pressure, which makes it a drug.

    Federal Food, Drug, and Cosmetic Act section 201(g)(1)(B) [21 U.S.C. 321(g)(1)(B)]
  4. Website claim states that Crystalized Raw Honey is antiviral, which makes it a drug.

    Federal Food, Drug, and Cosmetic Act section 201(g)(1)(B) [21 U.S.C. 321(g)(1)(B)]
  5. The products are new drugs (not shown safe and effective for the claimed uses) and are not approved by FDA for these uses.

    Federal Food, Drug, and Cosmetic Act sections 201(p), 301(d), and 505(a) [21 U.S.C. 321(p), 331(d), 355(a)]
  6. Goji Berries, Green Tea, and Raw Cacao Powder fail to bear adequate directions for their intended disease uses and are misbranded.

    Federal Food, Drug, and Cosmetic Act section 502(f)(1) [21 U.S.C. 352(f)(1)] and section 301(a) [21 U.S.C. 331(a)]

What FDA wants

FDA asks the company to notify it in writing within 15 working days of receipt of the specific steps taken to address the violations, including an explanation of steps to prevent recurrence and copies of related documentation. If corrective actions cannot be completed in that time, the company must state the reason and the time within which it will do so, and if it believes there is no violation, include its reasoning and supporting information.

Who should pay attention

  • food and beverage brands that publish health or disease claims online
  • online retailers and marketplaces listing cacao, tea, honey, or goji products
  • label reviewers and marketing teams for food and supplement products

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Natuzem

    FDA warned Mexico-based Natuzem for selling unapproved new drugs, including Reumofan Plus, to U.S. consumers online.

    High risk
  2. RonanRx, Inc. dba RonanRx

    FDA says RonanRx's website and X posts misbrand compounded semaglutide and tirzepatide with false or misleading claims.

    Low
  3. Calibrate IV Hydration

    FDA told Calibrate IV Hydration its umbilical cord and exosome IV products are unapproved drugs and unlicensed biologics.

    High risk
  4. Best Chinese Medicines LLC

    FDA warned Best Chinese Medicines LLC that five herbal products sold online are unapproved new drugs because their labeling claims to treat diseases.

    High risk